Clinical Scorecard: AAO: VisiPlate Two-Year VITA Follow-Up Presented
At a Glance
| Category | Detail |
|---|---|
| Condition | Clinical topic addressed by the source article: AAO |
| Key Mechanisms | VisiPlate is an investigational ultrathin, multichannel aqueous shunt designed to drain aqueous humor from the anterior chamber. Its microchannels are intended to maintain aqueous flow while reducing the risk of obstruction. |
| Target Population | Patients or participants described in the source article. |
| Care Setting | Care setting described in the source article. |
Key Highlights
- Two-year follow-up data from the VITA trial were presented at the 2026 American Academy of Ophthalmology Annual Meeting.
- VITA evaluates the investigational VisiPlate aqueous shunt in patients with primary open-angle glaucoma.
- The device uses multiple microchannels and a proprietary metamaterial and is designed to be considerably thinner than conventional glaucoma drainage implants.
- The article describes scarring and occlusion as factors that can limit the long-term performance of glaucoma drainage devices.
- Avisi is continuing VisiPlate evaluation through its US clinical development program, which includes an investigational device exemption study.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
VITA enrolled patients with primary open-angle glaucoma; the article provides no enrollment count or further patient characteristics.
VisiPlate is investigational and is being evaluated as a surgical approach to lower intraocular pressure. The article does not provide prescribing information, comparative results, or detailed safety outcomes.
Clinical Best Practices
- The article reports ongoing clinical evaluation of VisiPlate but does not provide clinical practice recommendations.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
